Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA grants orphan drug status to Mobius Mitosol
With the current status Mitosol now has three ODDs for glaucoma, pterygium, and refractive indications. Mobius president Ed Timm said this designation of Mitosol as an orphan drug
With the current status Mitosol now has three ODDs for glaucoma, pterygium, and refractive indications. Mobius president Ed Timm said this designation of Mitosol as an orphan drug
AP 12009-P001 Phase I/II trial is investigating the safety and tolerability of i.v. administration of trabedersen in 61 patients with advanced solid tumors known to overproduce TGF-b2, who
Results from a multicenter European study suggest that a new, large-core biopsy needle designed for use with an endoscopic ultrasound (EUS) scope may help to overcome limitations of
As per the terms of the agreement, Elite will conduct the laboratory stability studies, manufacturing and packaging for two generic products: Isradipine capsules USP, 2.5mg and 5mg and
MDV3100 is a triple-acting, pure androgen receptor antagonist in clinical development to treat advanced prostate cancer. Bone marrow biopsies are carried out in the study to evaluate the
The proposed dosing for ciclesonide HFA nasal aerosol is 74mcg once-daily (37mcg per spray; one-spray per nostril) Ciclesonide HFA is indicated for the treatment of symptoms of seasonal
The randomized, double-blind, double-dummy, active controlled study1 results suggested that Benolea reduces total cholesterol and plasma triglyceride levels in a. In the trial, Benolea and Captopril had lowered
Delhaize America operates supermarkets under various names such as Food Lion, Harveys Supermarket, Bloom, Bottom Dollar Food, and Reid’s. TheraMax is available for purchase in thousands of locations
Catumaxomab, an advanced Triomab trifunctional antibody (anti-EpCAM x anti-CD3), binds to cancer-associated surface antigens and recruit both T cells as well as accessory cells, such as macrophages, dendritic
Versartis develops new therapeutic proteins utilizing the proprietary Amunix half-life extension XTEN technology. XTEN is a novel hydrophilic sequence of natural amino acids and is expressed as a